CAR T Cell Therapy
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT06353828
Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 1, 2023
Completion: Apr 1, 2025
NCT05759728
A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
Phase: Phase 1/2
Start: Oct 24, 2023
Completion: Dec 31, 2027
Loading map...